Pullen R G, Candy J M, Morris C M, Taylor G, Keith A B, Edwardson J A
M.R.C. Neurochemical Pathology Unit, General Hospital, Newcastle upon Tyne, England.
J Neurochem. 1990 Jul;55(1):251-9. doi: 10.1111/j.1471-4159.1990.tb08846.x.
Evidence of a link between aluminium and Alzheimer's disease, parkinsonism-dementia of Guam, and dialysis encephalopathy raises questions regarding the role of this element in the pathogenesis of these conditions. Therefore, we have investigated the use of gallium-67 (67Ga) as a marker for brain uptake of aluminium. The binding of 67Ga to plasma proteins has been studied, and the blood-brain barrier permeability and autoradiographic distribution of this isotope in rat brain determined in vivo. The autoradiographic distribution of 125I-Fe-transferrin receptors in rat brain has also been determined in vitro. Results show that 67Ga was bound to plasma transferrin, entered the brain with a blood-brain barrier permeability of 2.48 x 10(-6) ml/min/g, and showed a marked regional distribution that was very similar to that of 125I-Fe-transferrin receptors. Our data suggest that the vulnerability of the hippocampus, amygdala, and cerebral cortex in conditions such as those mentioned above may be partly due to an increased uptake and deposition of aluminium in these regions by the iron transport system.
铝与阿尔茨海默病、关岛帕金森氏症 - 痴呆症以及透析性脑病之间存在关联的证据,引发了关于该元素在这些病症发病机制中作用的疑问。因此,我们研究了将镓 - 67(67Ga)用作大脑摄取铝的标志物。已对67Ga与血浆蛋白的结合进行了研究,并在体内测定了该同位素在大鼠脑中的血脑屏障通透性和放射自显影分布。还在体外测定了125I - 铁转铁蛋白受体在大鼠脑中的放射自显影分布。结果表明,67Ga与血浆转铁蛋白结合,以2.48×10(-6)ml/min/g的血脑屏障通透性进入大脑,并呈现出明显的区域分布,这与125I - 铁转铁蛋白受体的分布非常相似。我们的数据表明,在上述病症中,海马体、杏仁核和大脑皮层的易损性可能部分归因于铁转运系统使这些区域对铝的摄取和沉积增加。